1. Article
    How do patients with blood cancer respond to COVID-19 vaccination?
  2. Article
    Long term immune responses of patients with cancer to COVID-19 vaccines
  3. Article
    COVID-19 and cancer: the current state of knowledge
  4. Article
    How COVID-19 impacted cancer survivors in the United States
  5. Article
    Caring for cancer patients during the COVID-19 pandemic
  6. Article
    Protecting patients with hematologic cancers from COVID-19
  7. Article
    Long-term efficacy of the BNT162b2 vaccine against COVID-19 in patients with cancer
  8. Article
    Repurposing anticancer therapies for the treatment of COVID-19
  9. Article
    Why cancer patients are at a higher risk of severe COVID-19
  10. Article
    Efficacy of COVID-19 treatments in patients with cancer: an observational study
  11. Article
    Anti-CD20 therapy & coronavirus infection: The timing of vaccination and therapy on vaccine response
  12. Article
    Link between blood cancer and prolonged COVID-19
  13. Article
    Regular cancer screening in patients with Lynch Syndrome during the pandemic
  14. Article
    “Bruton tyrosine kinase”: a new drug target COVID-19 treatment?
  15. Article
    Does cancer treatment affect the severity of COVID-19?
  16. Article
    How the COVID-19 vaccines are a telling victory
  17. Article
    How cancer makes patients vulnerable to COVID-19 infection and its outcomes
  18. Article
    Do anticancer therapies for blood cancer increase the risk of severe coronavirus infection?
  19. Article
    In conversation with Dr Norman Sharpless: Covid-19 and its effects on cancer prevention
  20. Article
    COVID-19 and its role in redefining cancer clinical trial protocols